학술논문
Comparison of bortezomib versus lenalidomide maintenance therapy in newly-diagnosed, transplant-eligible multiple myeloma: Results from the phase III GMMG-HD4 and -MM5 trials
Document Type
Abstract
Author
Mai, Elias K.; Baertsch, Marc-A.; Hielscher, Thomas; Bertsch, Uta; Schlenzka, Jana; Salwender, Hans J.; Munder, Markus; Fuhrmann, Stephan; Duehrsen, Ulrich; Brossart, Peter; Neben, Kai; Raab, Marc S.; Jauch, Anna; Seckinger, Anja; Hose, Dirk; Luntz, Steffen; Sonneveld, Pieter; Lokhorst, Henk; Martin, Hans; Lindemann, Hans-Walter; Blau, Igor Wolfgang; Scheid, Christof; Weisel, Katja; Haenel, Mathias; Duerig, Jan; Goldschmidt, Hartmut
Source
In Clinical Lymphoma, Myeloma and Leukemia October 2019 19(10) Supplement:e43-e43
Subject
Language
ISSN
2152-2650